Emergent Biosolutions Stock Price Prediction
| EBS Stock | USD 2.18 0.11 4.80% |
Oversold Vs Overbought
42
Oversold | Overbought |
Emergent Biosolutions stock price prediction is an act of determining the future value of Emergent Biosolutions shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Emergent Biosolutions' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Emergent Biosolutions and does not consider all of the tangible or intangible factors available from Emergent Biosolutions' fundamental data. We analyze noise-free headlines and recent hype associated with Emergent Biosolutions, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Emergent Biosolutions' stock price prediction:Quarterly Earnings Growth 0.022 | EPS Estimate Next Quarter (0.22) | EPS Estimate Current Year (2.00) | EPS Estimate Next Year 3.67 | Wall Street Target Price 5 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Emergent Biosolutions based on different types of headlines from major news networks to social media. The Emergent stock price prediction module provides an analysis of price elasticity to changes in media outlook on Emergent Biosolutions over a specific investment horizon. Using Emergent Biosolutions hype-based prediction, you can estimate the value of Emergent Biosolutions from the perspective of Emergent Biosolutions response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Emergent Biosolutions using Emergent Biosolutions' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Emergent using crowd psychology based on the activity and movement of Emergent Biosolutions' stock price.
Emergent Biosolutions Short Interest
A significant increase or decrease in Emergent Biosolutions' short interest from the previous month could be a good indicator of investor sentiment towards Emergent. Short interest can provide insight into the potential direction of Emergent Biosolutions stock and how bullish or bearish investors feel about the market overall. An investor who is long Emergent Biosolutions may also wish to track short interest. As short interest increases, investors should be becoming more worried about Emergent Biosolutions and may potentially protect profits, hedge Emergent Biosolutions with its derivative instruments, or be ready for some potential downside.
200 Day MA 3.1874 | Short Percent 0.1802 | Short Ratio 2.64 | Shares Short Prior Month 6.2 M | 50 Day MA 2.4184 |
Emergent Biosolutions Hype to Price Pattern
Investor biases related to Emergent Biosolutions' public news can be used to forecast risks associated with an investment in Emergent. The trend in average sentiment can be used to explain how an investor holding Emergent can time the market purely based on public headlines and social activities around Emergent Biosolutions. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Emergent Biosolutions' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Emergent Biosolutions.
Emergent Biosolutions Implied Volatility | 132.49 |
Emergent Biosolutions' implied volatility exposes the market's sentiment of Emergent Biosolutions stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Emergent Biosolutions' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Emergent Biosolutions stock will not fluctuate a lot when Emergent Biosolutions' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Emergent Biosolutions. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Emergent Biosolutions to buy its stock at a price that has no basis in reality. In that case, they are not buying Emergent because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Emergent Biosolutions after-hype prediction price | USD 2.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Emergent |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Emergent Biosolutions' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Emergent Biosolutions After-Hype Price Prediction Density Analysis
As far as predicting the price of Emergent Biosolutions at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Emergent Biosolutions or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Emergent Biosolutions, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Emergent Biosolutions Estimiated After-Hype Price Volatility
In the context of predicting Emergent Biosolutions' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Emergent Biosolutions' historical news coverage. Emergent Biosolutions' after-hype downside and upside margins for the prediction period are 0.11 and 13.88, respectively. We have considered Emergent Biosolutions' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Emergent Biosolutions is abnormally volatile at this time. Analysis and calculation of next after-hype price of Emergent Biosolutions is based on 3 months time horizon.
Emergent Biosolutions Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Emergent Biosolutions is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Emergent Biosolutions backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Emergent Biosolutions, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.81 | 11.70 | 0.20 | 0.09 | 5 Events / Month | 4 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.18 | 2.18 | 0.00 |
|
Emergent Biosolutions Hype Timeline
On the 25th of April Emergent Biosolutions is traded for 2.18. The entity has historical hype elasticity of -0.2, and average elasticity to hype of competition of -0.09. Emergent is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.81%. %. The volatility of related hype on Emergent Biosolutions is about 10446.43%, with the expected price after the next announcement by competition of 2.09. About 79.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.17. Some equities with similar Price to Book (P/B) outperform the market in the long run. Emergent Biosolutions has Price/Earnings To Growth (PEG) ratio of 1.55. The entity recorded a loss per share of 14.85. The firm had not issued any dividends in recent years. Considering the 90-day investment horizon the next forecasted press release will be in about 5 days. Check out Emergent Biosolutions Basic Forecasting Models to cross-verify your projections.Emergent Biosolutions Related Hype Analysis
Having access to credible news sources related to Emergent Biosolutions' direct competition is more important than ever and may enhance your ability to predict Emergent Biosolutions' future price movements. Getting to know how Emergent Biosolutions' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Emergent Biosolutions may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TERN | Terns Pharmaceuticals | (0.75) | 8 per month | 5.23 | (0.01) | 8.64 | (8.38) | 27.76 | |
| AMLX | Amylyx Pharmaceuticals | 0.04 | 6 per month | 0.00 | (0.15) | 6.96 | (8.30) | 103.39 | |
| ABOS | Acumen Pharmaceuticals | 0.1 | 7 per month | 0.00 | (0.02) | 7.28 | (5.98) | 23.58 | |
| INZY | Inozyme PharmaInc | (0.35) | 8 per month | 4.39 | (0.0005) | 8.83 | (8.42) | 25.32 | |
| DAWN | Day One Biopharmaceuticals | 0.40 | 10 per month | 3.79 | 0.03 | 6.06 | (5.40) | 20.03 |
Emergent Biosolutions Additional Predictive Modules
Most predictive techniques to examine Emergent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Emergent using various technical indicators. When you analyze Emergent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Emergent Biosolutions Predictive Indicators
The successful prediction of Emergent Biosolutions stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Emergent Biosolutions, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Emergent Biosolutions based on analysis of Emergent Biosolutions hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Emergent Biosolutions's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Emergent Biosolutions's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0202 | 0.018 | Price To Sales Ratio | 0.12 | 0.11 |
Story Coverage note for Emergent Biosolutions
The number of cover stories for Emergent Biosolutions depends on current market conditions and Emergent Biosolutions' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Emergent Biosolutions is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Emergent Biosolutions' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Emergent Biosolutions Short Properties
Emergent Biosolutions' future price predictability will typically decrease when Emergent Biosolutions' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Emergent Biosolutions often depends not only on the future outlook of the potential Emergent Biosolutions' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Emergent Biosolutions' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.1 M | |
| Cash And Short Term Investments | 642.6 M |
Check out Emergent Biosolutions Basic Forecasting Models to cross-verify your projections. For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Emergent Stock analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.022 | Earnings Share (14.85) | Revenue Per Share 20.494 | Quarterly Revenue Growth (0.16) | Return On Assets (0.05) |
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if Emergent Biosolutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.